Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
Ting Chang(Taipei Veterans General Hospital), Shou‐Dong Lee(National Yang Ming Chiao Tung University)
Cited by 7
Related Papers
Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats
|PLoS ONE|2017|11
Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats
|International Journal of Molecular Sciences|2019|9
Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat
|Journal of Pharmacology and Experimental Therapeutics|2018|1